Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Bivalirudin PCI Registry in HIT/HITTS Patients

To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention

Inclusion Criteria:

• Clinically Documented History of HIT/HITTS
• Suspicion of HIT/HITTS

Exclusion Criteria:

• Bleeding Diathesis
• Ischemic Stroke
• Chronic Thrombocytopenia
• Hematologic Malignancy
• Contraindication to bivalirudin
• Pregnant or nursing mothers